Research Article
Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
Table 5
Antibiotic resistance pattern to Acinetobacter baumannii isolates.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AMP: ampicillin, AMC: amoxicillin/clavulanate, CFX: cefuroxime, CXM: cefuroxime axetil, FOX: cefoxitin, CFM: cefixime, CAZ: ceftazidime, CRO: ceftriaxone, IPM: imipenem, MEM: meropenem, AMK: amikacin, GEN: gentamicin, CIP: ciprofloxacin, FOS: fosfomycin, NIT: nitrofurantoin, SXT: trimethoprim-sulfamethoxazole, PIP: piperacillin, TZP: piperacillin-tazobactam, FEP: cefepime, ATM: aztreonam, NET: netilmicin, TOB: tobramycin, LVX: levofloxacin, STR: streptomycin, TET: tetracycline, TGC: tigecycline, CST: colistin, CLI: clindamycin, CPD: cefpod-oxime, DOX: doxycycline, NOR: norfloxacin, CLR: clarithromycin, ERY: erythromycin. MDR: multidrug-resistant, XDR: extensively drug resistance, S: suspectable, R: resistant. |